Dopamine-receptor blockade and tardive dyskinesia

Trichloroethylene and its metabolite TaClo lead to degeneration of substantia nigra dopaminergic neurones: Effects in wild type and human A30P mutant α-synuclein mice.

Neuroscience letters·2019

Hospital usage of TOXBASE in Great Britain: Temporal trends in accesses 2008 to 2015.

Human & experimental toxicology·2018

Overdose in young children treated with anti-reflux medications: Poisons enquiry evidence of excess 10-fold dosing errors with ranitidine.

Human & experimental toxicology·2017

Circulating acetaminophen metabolites are toxicokinetic biomarkers of acute liver injury.

Clinical pharmacology and therapeutics·2016

Comprehensive microRNA profiling in acetaminophen toxicity identifies novel circulating biomarkers for human liver and kidney injury.

Scientific reports·2015

Diquat causes caspase-independent cell death in SH-SY5Y cells by production of ROS independently of mitochondria.

Archives of toxicology·2015

Multivessel coronary artery bypass grafting via small thoracotomy versus sternotomy (MIST): an investigator-initiated, international, open-label, randomised controlled trial.

Lancet (London, England)·2026

Efficacy and safety of once-daily oral zenagamtide, a novel unimolecular GLP-1 and amylin receptor agonist, in adults with type 2 diabetes: a multicentre, randomised, parallel, double-blind, placebo-controlled, dose-finding, phase 2 trial.

Lancet (London, England)·2026

Psoriasis.

Lancet (London, England)·2026

Deramiocel heart-derived cellular therapy in advanced Duchenne muscular dystrophy (HOPE-3): a phase 3, randomised, double-blind, placebo-controlled trial.

Lancet (London, England)·2026

Ralinepag for the treatment of pulmonary arterial hypertension (ADVANCE OUTCOMES): a randomised, double-blind, placebo-controlled phase 3 study.

Lancet (London, England)·2026

Oral step-down, optimal drug, and total duration of antibiotic treatment in African children hospitalised with severe community-acquired pneumonia (PediCAP): a factorial randomised controlled trial.

Lancet (London, England)·2026

PAI-1 As a Therapeutic Target: A State-of-the-Art Review.

Seminars in thrombosis and hemostasis·2026

Beyond mood: the neurobiological rationale for using SSRIs and SNRIs in the care of inflammatory bowel disease and disorders of gut-brain interaction.

Minerva gastroenterology·2026

Community Advisory Board Members Speak Out: Insights From an Opioid Overdose Study.

Health expectations : an international journal of public participation in health care and health policy·2026

Who Achieves Minimal and Very Low Disease Activity in Psoriatic Arthritis? An Analysis of the CorEvitas Psoriatic Arthritis/Spondyloarthritis Registry.

The Journal of rheumatology·2026

Disparities in the access to and use of biologic and targeted synthetic treatments in patients with inflammatory rheumatic and musculoskeletal diseases: a scoping review.

EULAR rheumatology open·2026

Onset of Motor Complications and Medication Dose in Newly Diagnosed and Treated Parkinson's Disease.

Parkinson's disease·2026

Related Experiment Videos

Dopamine-receptor blockade and tardive dyskinesia

Related Concept Videos

Trichloroethylene and its metabolite TaClo lead to degeneration of substantia nigra dopaminergic neurones: Effects in wild type and human A30P mutant α-synuclein mice.

Hospital usage of TOXBASE in Great Britain: Temporal trends in accesses 2008 to 2015.

Overdose in young children treated with anti-reflux medications: Poisons enquiry evidence of excess 10-fold dosing errors with ranitidine.

Circulating acetaminophen metabolites are toxicokinetic biomarkers of acute liver injury.

Comprehensive microRNA profiling in acetaminophen toxicity identifies novel circulating biomarkers for human liver and kidney injury.

Diquat causes caspase-independent cell death in SH-SY5Y cells by production of ROS independently of mitochondria.

Multivessel coronary artery bypass grafting via small thoracotomy versus sternotomy (MIST): an investigator-initiated, international, open-label, randomised controlled trial.

Efficacy and safety of once-daily oral zenagamtide, a novel unimolecular GLP-1 and amylin receptor agonist, in adults with type 2 diabetes: a multicentre, randomised, parallel, double-blind, placebo-controlled, dose-finding, phase 2 trial.

Psoriasis.

Deramiocel heart-derived cellular therapy in advanced Duchenne muscular dystrophy (HOPE-3): a phase 3, randomised, double-blind, placebo-controlled trial.

Ralinepag for the treatment of pulmonary arterial hypertension (ADVANCE OUTCOMES): a randomised, double-blind, placebo-controlled phase 3 study.

Oral step-down, optimal drug, and total duration of antibiotic treatment in African children hospitalised with severe community-acquired pneumonia (PediCAP): a factorial randomised controlled trial.

PAI-1 As a Therapeutic Target: A State-of-the-Art Review.

Beyond mood: the neurobiological rationale for using SSRIs and SNRIs in the care of inflammatory bowel disease and disorders of gut-brain interaction.

Community Advisory Board Members Speak Out: Insights From an Opioid Overdose Study.

Who Achieves Minimal and Very Low Disease Activity in Psoriatic Arthritis? An Analysis of the CorEvitas Psoriatic Arthritis/Spondyloarthritis Registry.

Disparities in the access to and use of biologic and targeted synthetic treatments in patients with inflammatory rheumatic and musculoskeletal diseases: a scoping review.

Onset of Motor Complications and Medication Dose in Newly Diagnosed and Treated Parkinson's Disease.

Related Experiment Videos

Dopamine-receptor blockade and tardive dyskinesia

Related Concept Videos

Related Articles